BACKGROUND: A central distribution of adipose tissue is frequently associated with cardiovascular disease (CVD) and its risk factors. METHODS: Clinical usefulness of waist-to-hip ratio (WHR) for predicting the risk of cardiovascular events, estimated with models based on data from the Framingham and Prospective Cardiovascular Mu È nster (PROCAM) studies was evaluated. SUBJECTS: These were 552 men and 160 women, asymptomatic and at risk for CVD, aged 30 ± 74 y, recruited from an ongoing risk factor screening program conducted at worksites. RESULTS: Abdominal fatness was a strong predictor of cardiovascular complications in subjects whose WHR was in the top quintile (b b 0.98 for men and b b 0.91 for women). The estimated percentage rate of coronary heart disease (CHD, P`0.01) and death (P`0.01), myocardial infarction (P`0.01), stroke (P`0.01), total CVD (P`0.001) and death (P`0.01) increased with increasing quintile of WHR in men and women. In the highest WHR, the number of subjects exceeding a 15% risk of developing a coronary event over the next 10 y was more than two-fold greater (odds ratio (OR) 2.60 (con®dence intervals (CI) 1.09 ± 6.54) than in the lowest WHR quintiles. Similar six-year myocardial infarction (MI) risks at each quintile of WHR were observed in men in both Framingham and PROCAM models. In the overall population, CHD estimates increased with increasing quintiles of WHR with the Framingham model and an adapted model for estimating probabilities of disease in the French population of the Pre Â vention Cardiovasculaire en Me Â decine du Travail (PCV-METRA) group. CONCLUSION: Abdominal deposition of fat assessed by WHR may be of strong clinical value for predicting high risk of cardiovascular events.
Introduction
In France and European countries cardiovascular diseases (CVD) remain the leading cause of morbidity and mortality. 1 ± 3 An important number of premature deaths (`65 y) can be prevented with adequate screening programs at the worksite. In occupational medicine, subjects with high risk of CVD are generally identi®ed as those presenting with hypertension, hypercholesterolaemia or a history of smoking. By referring to our center a large number of apparently healthy subjects with these risk factors, it was possible to detect the ones with preclinical extracoronary and coronary atherosclerosis, who were candidate for fairly aggressive preventive treatment and special follow-up. 4 ± 6 At the worksite, the identi®cation of people with CVD risk required simple cost-effective measurements. An inexpensive screening method for the prediction of cardiovascular risk is the anthropometric measure of waist-to-hip (WHR). As ®rst described by Vague in 1956 7 and largely con®rmed by others, 8 ± 10 an android distribution of adipose tissue (upper body obesity) is frequently associated with CVD and its risk factors. Central obesity assessed by the measurement of WHR may better predict CVD risk and metabolic alteration than other anthropometric indicators of total adiposity. 8, 11, 12 Measurement of WHR could be appropriate in clinical practice and occupational medicine, to ®nd subjects with a cluster of multiple CVD risk factors, including hypertension, dyslipidaemia, glucose intolerance or diabetes. Prospective studies have shown a positive association between the pattern of body shape and the occurrence of cardiovascular events such as myocardial infarction (MI), angina pectoris, stroke and death from coronary heart disease (CHD). 11 ± 14 A large number of longitudinal studies provide different models, enabling the calculation of total cardiovascular risk factors for an individual. 15 ± 17 Among these, the estimation of CVD and death risk derived from the Framingham study is the most wellknown.
We evaluated the clinical usefulness of WHR for predicting the risk of cardiovascular events, estimated with different models based on epidemiological studies, in a selected population with risk factors for CVD, but without evidence of coronary, cerebral or peripheral vascular disease.
Methods

Study subjects
Subjects were recruited from an ongoing risk-factor screening program, conducted at worksites for employees of several companies within the Paris area, by occupational health physicians in the Pre Âven-tion Cardiovasculaire en Me Âdecine du Travail (PCV METRA group). 4, 6 After their consent was obtained, 712 subjects, (552 men and 160 women) were included because of the presence of traditional risk factors and studied from January 1993±April 1996. After complete examination during a one-day hospitalization, subjects aged 30±74 y were included if they presented at least one risk factor, such as essential hypertension, primary hypercholesterolaemia or current smoking and if they were free from CVD, including stroke, transient ischaemia, CHD, congestive heart failure and intermittent claudication.
Evaluation of risk factors
We evaluated risk factors that were considered standard in the Framingham Study 18 and in the Prospective Cardiovascular Mu Ènster (PROCAM) Study. 17 With subjects in the supine position for at least 10 min after 14 h fasting, we measured serum cholesterol levels, with the use of enzymatic methods to determine total and high-density lipoprotein (HDL) cholesterol concentrations after the precipitation of low-density lipoproteins (LDL) and very-low-density lipoproteins (VLDL) by phosphotungstic acid and magnesium chloride. 4, 6 Subjects with diseases or factors causing secondary hypercholesterolaemia were excluded from the study. Hypercholesterolaemia was de®ned as a total cholesterol level of !6.2 mmolal, the use of lipid-lowering drug treatment or both. 19 Of the subjects, 76 were receiving lipid-lowering treatment. The type of drug therapy was distributed as follows: ®brate derivative (44 subjects) and HMG-CoA reductase inhibitor (32 subjects). Blood pressure (BP) was measured in the arm, with the subject in the supine position for at least 10 min and was recorded as the average of at least three consecutive measurements by standard sphygmomanometric procedure. 4, 6 Essential hypertension was established on the basis of appropriate laboratory tests and subjects with secondary hypertension were excluded from the study. Hypertension was de®ned by systolic BP (SBP) of !160 mmHg andaor diastolic BP (DBP) of !95 mmHg, the use of hypertensive treatment or a combination. 20 Of the subjects, 137 were receiving antihypertensive treatment and the type of antihypertensive drug was distributed as follows: diuretic (nine subjects), beta-blocker (24 subjects), angiotensin-converting enzyme inhibitor (34 subjects), calcium channel blocker (24 subjects), and a combination of two or three of these drugs (46 subjects). Current smoking was carefully assessed by questioning the subjects and was de®ned as regular smoking each day or having stopped within the last year. Blood glucose level was measured after a 14 h fast, and diabetes was de®ned as fasting blood glucose level !7.7 mmolal, the use of antidiabetic drug treatment, or both. 4 Of the subjects, 14 were receiving antidiabetic therapy and the type of drug was distributed as follows: insulin (one subject), sulphonylurea (eight subjects), biguanide (three subjects) and a combination of the last two drugs (two subjects). Left ventricular hypertrophy (LVH) was measured by electrocardiogram (ECG-LVH) and de®ned as present, according to the criteria of Sokolow and Lyon. 21 Plasma ®brinogen was determined according to the thrombin time method described by Clauss.
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Prediction equation for CVD end-points Different equations to predict cardiovascular risk to individual subjects, derived from epidemiological studies and based on measurement of several known risk factors, were calculated. The most recognized and the more complete is the prediction equation developed by the Framingham Heart Study which allows the risk estimation of an individual aged 30±74 y, over a range of 4±12 y for several CVD end-points.
The Framingham equation was deduced from a nonproportional hazard Weibull accelerated failure time regression model, where the probability of a cardiovascular event was calculated according to risk factors status and a constant term l. Full hypothesis and equation of the model should be read in the original paper. 18 Then, the risk of CHD and death, MI, stroke, CVD and death at 10 y were calculated for each subject by entering into the equations of the Framingham risk model the following variables 18 : age, gender, SBP, total to HDL cholesterol ratio, current smoking coded as present or absent, diabetes coded as present or absent and ECG-LVH coded as present or absent.
We also calculated the coef®cient of the multiple logistic function derived from the PROCAM study, one of the largest prospective epidemiological studies of CHD risk markers in Europe. 17 The PROCAM equation estimated the probability of men suffering a MI within six years, by entering the following variables: age, SBP, cholesterol, HDL-cholesterol ®brino-gen, cigarette smoking, diabetes mellitus, angina pectoris and MI, in family history.
Lastly, we calculated the risk of CHD in our population using a modi®ed Framingham model, which allowed us to reduce the overestimation of Predictive value of waist-to-hip ratio on cardiovascular risk events JL Megnien et al this model when we applied it to a population with low CHD mortality. Calculation was based on data from the French PCV METRA study, a follow-up of the main CHD risk factors in workers from 20 large ®rms in the Ile de France. 4, 6 We previously demonstrated 23 that the sole modi®cation of the constant term l in the accelerated failure time Framingham model, which re¯ects the difference in the basal CHD risk of the French population, enables to better predict CHD in the PCV-METRA sample. 23 
Anthropometric evaluation
Body weight was measured using a balance scale, with subjects in light clothing and without shoes. Height was measured with a vertical ruler. Body mass index (BMI) was obtained by dividing body weight in kilograms by height in meters squared (kgam 2 ). Waist (W) was measured using a cloth tape just above the level of the lateral iliac crest, below the lower costal arch at the end of gentle expiration. Hip (H) was measured at the level of the great trochanters. 24 Quintile cutpoints for WHR were 0. Results Table 1 shows mean AE s.d. variables of the study population grouped by gender. In the pooled population, the prevalence of risk factors was 47% both for hypercholesterolaemia and hypertension, 29% for smoking, 5% for diabetes and 3.5% for ECG-LVH. Table 2 shows the mean values for age, SBP, totalto-HDL cholesterol ratio, ®brinogen, percentage of current smoking, diabetes and ECG-LVH in quintiles of WHR strati®ed by gender. Signi®cant positive associations were found between WHR and SBP (P`0.05), total-to-HDL-cholesterol ratio (P`0.01 for men and P`0.001 for women), ®brinogen (P`0.001 for men and P`0.02 for women) and diabetes (P`0.001 for men and P`0.01 for women). In contrast, the association with age was only signi®cant for men (P`0.001).
WHR was associated with estimated 10 year cardiovascular morbidity and mortality. The estimated percentage rate of CHD (P`0.001) and death (P`0.01), MI (P`0.01), stroke (P`0.01) and total CVD (P`0.001) and death (P`0.01) increased with increase of the WHR in men and women (Figure 1 ). Predictive value of waist-to-hip ratio on cardiovascular risk events JL Megnien et al Similar associations with estimated ten-year cardiovascular morbidity and mortality with waist and BMI were observed for both sexes. Figure 2 shows 10 y CHD risk associated with waist girth alone.
The combined in¯uence of BMI and WHR on the estimation of risk for CHD after stratifying the whole population into quintiles for each of these measurements is described in Figure 3 . Within BMI quintiles, the risk of CHD increased with increasing WHR. In addition, WHR independently predicted CHD when BMI was taken into account (P`0.001). While there was no interactive effect between WHR and BMI quintiles (P 0.29), a signi®cant interaction was found between waist and BMI quintiles (P`0.01) on the estimated CHD risk.
The number of subjects exceeding a 15% risk of developing a CHD event over the next 10 y increased with increasing quintile of waist, WHR and BMI (Table 3) . However the OR for 15%±10 y CHD, in subjects with anthropometric levels in the upper vs the lower quintiles, were signi®cant for WHR (2.60, CI 1.09±6.54), borderline for waist (3.30, CI 0.98± Figure 1 Estimated 10 y percentage rate of coronary heart disease (CHD), coronary heart death (CHD death), myocardial infarction (MI), stroke, cardiovascular disease (CVD) and cardiovascular disease death (CVD death) risks in men and women according with waist-to-hip ratio (WHR) quintiles. Values are mean AE s.e.m. Predictive value of waist-to-hip ratio on cardiovascular risk events JL Megnien et al 11.27 ) and non signi®cant for BMI (2.03, CI 0.91± 4.56) ( Table 3) . Figure 4 (Top) displays the six-year MI risk, estimated by quintiles of WHR using the Framingham model and compared to the PROCAM model using only the male subjects of the study population. Similar percentage risks of MI were observed with these models at each quintile for WHR. 
Figure 3
Percentage probability of coronary heart disease (CHD) according to quintiles of waist-to-hip ratio (WHR) and body mass index (BMI) in the overall population. Waist-to-hip ratio 11a151 (7) 36a145 (25) 32a134 (24) 46a131 (35) Top: Estimated six-year myocardial infarction (MI) risks in men by waist-to-hip ratio (WHR) quintiles from the Pre Â vention Cardiovasculaire en Me Â decine du Travail (PCV METRA) sample using the Framingham model 18 and the Prospective Cardiovascular Mu È nster (PROCAM) model. 17 Bottom: Estimated 10 y coronary heart disease (CHD) risks in the overall population by waist-to-hip ratio (WHR) quintiles from the PCV METRA sample using the Framingham model 18 and the modi®ed Framingham model 23 to predict CHD risk in the PCV METRA population. Values are mean AE s.e.m.
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Discussion
The results of our cross-sectional study in asymptomatic men at risk of CVD is in agreement with previous longitudinal investigations indicating that centralized distribution of body fat, assessed by WHR measurements, is associated with increased CHD, MI, stroke and death. 11, 12 The analysis of the risk factors derived from the Framingham study for calculating the absolute risk in subjects of our population showed that WHR increased independently with SBP, cholesterol to HDL ratio, ®brinogen and diabetes in both sexes, but only with advancing age for men. In contrast, no association existed between WHR and the number of smokers or subjects with ECG-LVH. The absence of association of abdominal fatness and left ventricular hypertrophy is a striking result because overweight has been reported to be associated with an increase of left ventricular mass. 25, 26 Abdominal obesity is a strong predictor of cardiovascular complications in subjects with risk factors: there was about a two-fold increase in the risk at 10 y of CHD and death, total CVD and death, MI and stroke in subjects whose WHR was in the ®fth quintile (b 0.98 for men and b 0.91 for women) compared with the ®rst quintiles. Although the predicted risk of CVD increased across the WHR quintiles in both sexes, women attained at the higher quintile of WHR half the risk achieved by men. In addition, the higher risk reached by women with the greater abdominal fatness nearly corresponded to the lower risk of cardiovascular complication observed in men with the smaller WHR. However the risk of suffering a stroke seemed to increase with WHR in a proportional manner in both sexes.
The relation between WHR and BMI should be considered when interpreting the prevalence of cardiovascular complication. BMI is highly correlated with most risk factors for CHD. In a recent study of the Framingham offspring population, using the CHD risk prediction chart, a two-fold age-adjusted increase in the 10 y risk of CHD was observed in subjects with a BMI ! 30 kgam 2 compared to those with`21 kga m 2 . 27 Analysis of combined in¯uence of BMI and WHR on CHD risk in the present work showed a predominant in¯uence of abdominal fatness assessed by WHR, compared to absolute body fatness. It is surprising that CHD risk did not increase at increasing quintiles of BMI, except in subjects in the upper WHR quintile. This may indicate that abdominal fatness, assessed by WHR, is a more sensitive marker in the individualization of subjects with a high risk of cardiovascular events. The fact that the association between WHR and CHD risk was present in all quintiles of BMI distribution indicates that overweight per se is not necessary for abdominal fatness to have a negative cardiovascular effect. 10, 11 The measurement of waist girth alone may also be a useful marker of CHD risk, as demonstrated by the association with the predicted 10 y coronary disease risk. However, while waist girth and BMI interact to predict the risk of CHD, a lack of a signi®cant interaction between WHR and BMI exist, suggesting that the risk association with increasing WHR is not affected by simultaneous variations in BMI.
In order to individualize asymptomatic subjects with high absolute risk of developing a CHD event in the next decade, we determined those exceeding a 15% CHD risk in our working population who had traditional risk factors (smoking, hypertension, hypercholesterolaemia) for the PCV METRA study. Although this population is already at relatively high risk, the analysis was performed only in participants at high risk for CHD, since these individuals have most to gain by risk factor reduction. The choice of 15% as a value to include subjects in our population is based on the concept that the decision to treat must be founded on the result of randomized drug studies, and that the individual bene®t of treating a subject must be evaluated on the basis of his or her pretreatment coronary risk. 28 The recent West of Scotland Coronary Prevention Study (WOSCOPS) 29 showed that the bene®t of lipid lowering drug therapy, in preventing CHD events, substantially outweighs any harm when the risk of CHD events (MI, coronary death) is !1.5% per year. Other guidelines, like the European Task Force, recommended a level of 20%-10 y mortality risk, based on the risk function derived from the Framingham Study, for intensive risk modi®cation effort. 30 When comparing the highest and lowest quintiles of WHR, the OR for b 15% CHD risk over the next 10 y was more than two-fold. Therefore, the simple, easy and cost-effective measurement of waist and hip using a cloth tape at the worksite allowed us to identify a large number of asymptomatic subjects with a high risk of CVD. Indeed, 50% of the subjects included in the highest quintile of WHR were at high risk of CHD and would experience some bene®t from treatment.
The application of the Framingham model may overestimate CHD incidence in our population. This was observed when other CHD prediction models, built in countries with high cardiovascular mortality, were applied to a population with lower cardiovascular mortality. 15, 23, 31 However, our study did not include subjects from the general population ± they were recruited because of the presence of traditional risk factors. Consequently, a limitation of the study is that its results cannot be generalized to the population at large. We also tested the use of two other models for evaluating the usefulness of WHR in predicting the risk of cardiovascular events. First the PROCAM study, which has some similarities with the PCV METRA study, because both included people at work. By comparing the six-year MI estimated by quintile of WHR, between the Framingham model and the PROCAM model in the male subject of our population, similar risk of events at each quintile of WHR was observed. The most important difference between these Predictive value of waist-to-hip ratio on cardiovascular risk events JL Megnien et al two models concerned the inclusion of plasma ®bri-nogen in the PROCAM equation, which was found in this study to be an independent risk indicator of CHD if age, BP, smoking, diabetes mellitus, angina pectoris, family history of MI, total and HDL cholesterol were taken into account. 17 The inclusion of plasma ®brino-gen in the PROCAM model may counterbalance the overestimation of CHD incidence reported with the use of the Framingham model. We observed in our population that plasma ®brinogen increased with increasing quintiles of WHR.
The other model tested in the present study adapted the constant term of the Framingham model to account for the difference in the basal CHD morbidity of the PCV METRA population. 23 Both of these models demonstrated similar increase in CHD risk with increasing abdominal fatness, but with 40% lower extent in the PCV METRA population. Thus, even in a low risk population, the modi®ed Framingham model provides an estimate of CHD risk and can distinguish high-risk from low risk persons in such populations. The important differences between the two models were in agreement with the paradox of the low CHD of the French, in the presence of similar prevalence of cardiovascular risk factors. 23 Epidemiological studies showed that the mortality rate from CHD is much lower in France than in other industrialized countries, such as the USA and the UK. 32 Moderate alcohol consumption, through the action of HDL cholesterol, and inhibition of platelets aggregation is believed to protect from CHD in France. 33 Further research is needed to determine if the socalled`French paradox' can by itself explain how people in France with a high WHR had a 40% reduced CHD risk, or that other risk or protective factors are involved in these differences.
Conclusion
The abdominal deposition of fat assessed by WHR measurements may be of strong clinical value for predicting subjects with a cluster of several risk factors and presenting high risk of cardiovascular complications. This simple and sensitive method for identifying individuals at high cardiovascular risk merits to be used in clinical practical and especially in primary health organizations, such as occupational medicine.
